EcoDrugPlus

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSUMAG00000017201
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSUMAG00000020317
Gene Symbol: AVPR1A
4 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSUMAG00000003978
Gene Symbol: AVPR1B
3 Cross references
132 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSUMAG00000022084
Gene Symbol: AHR
4 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSUMAG00000002729
Gene Symbol: AURKA
4 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSUMAG00000017269
Gene Symbol: AURKB
4 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSUMAG00000004196
Gene Symbol: AURKC
4 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSUMAG00000002549
Gene Symbol: BACE1
4 Cross references
217 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSUMAG00000002793
Gene Symbol: BDKRB1
2 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSUMAG00000002798
Gene Symbol: BDKRB2
4 Cross references
356 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSUMAG00000024278
Gene Symbol: BCHE
4 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSUMAG00000018752
Gene Symbol: CALCRL
4 Cross references
147 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).